• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
TAH
Click for more information
0.00% $1.57

Third Age Health Services Limited Ordinary Shares - News & Media

watchlist Created with Sketch. Add to my watchlist
Healthcare

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

No News & Media currently available.

(20min delay)
Last
$1.57 		Change
0.000(0.00%) 		Mkt cap ! n/a
Open High Low Value Volume
0.0¢ $1.59 $1.57 $160 103

Buyers (Bids)

No. Vol. Price($)
0 3 $1.50
 

Sellers (Offers)

Price($) Vol. No.
$1.57 336 0
Last trade - 10.53am 05/07/2024 (20 minute delay) ?
TAH (NZSX) Chart

Top Stories

Tivan and EARTH AI gear up to commence fresh drilling at Sandover lead-silver project, NT

Tivan and its project partner Earth AI are readying up the drill rig to kick off a fresh run at the NT-based Sandover lead-silver project.
Red Hill Minerals Signs $6.5 Million Agreement with Peel Mining to Explore Curnamona Project, NSW Red Hill Minerals (ASX:RHI) has executed a conditional binding Heads of Agreement with Peel Far West Pty, a subsidiary of ASX-listed Peel Mining (ASX: PEX), to explore the Curnamona Project in New South Wales.
KGL sniffs 19% Cu from drilling at Rockface play in NT KGL Resources Ltd has discovered copper grading beyond 19% through exploration at its Rockface prospect in the Northern Territory.
The Big Deal: Free-to-air TV swings the axe, but will it be enough as enormous sports deal bills loom?  What’s left for traditional media stocks after Meta pulled the pin on its news content deal? How will channels 7 (ASX:SVW) and 9 (ASX:NEC) afford expensive sports deals as audiences move to streaming? Former AFL star Warren Tredrea discusses this and more with Unmade media analyst Tim Burrowes.
British study shows Clinuvel drug effective on DNA of UV-damaged skin Clinuvel Pharmaceuticals Ltd has reported final results of its study of the efficacy of afamelanotide to repair the DNA of damaged skin.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.